Viewing Study NCT00329459


Ignite Creation Date: 2025-12-24 @ 3:03 PM
Ignite Modification Date: 2025-12-25 @ 11:22 PM
Study NCT ID: NCT00329459
Status: COMPLETED
Last Update Posted: 2016-10-24
First Post: 2006-05-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as TREXIMA, for Menstrual Migraine in Women With Dysmenorrhea
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module